nodakenin,
Nodakenin,
495-31-8,
(+)-Marmesinin,
UNII-S2KTH28M3N,
AC1L2JF8,
S2KTH28M3N,
MLS000563463,
CHEBI:7607,
CHEMBL459825,
(2R)-2-[1-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-ethyl]-2,3-dihydrofuro[3,2-g]chromen-7-one,
Nodakenetin, beta-D-glucopyranoside,
cid_73191,
AC1Q6A33,
MEGxp0_001251,
HMS2208A17,
ZINC4097985,
8185AH,
BDBM50242388,
MFCD09953919,
AKOS000276878,
2-[(2r)-7-oxo-2,3-dihydro-7h-furo[3,2-g]chromen-2-yl]propan-2-yl |A-d-glucopyranoside,
NCGC00247564-01,
AN-45296,
SMR000232306,
FT-0688359,
N2465,
C09279,
I07-0255,
Q-100554,
(2R)-2-[2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl]-2,3-dihydrofuro[3,2-g]chromen-7-one,
7H-Furo(3,2-g)(1)benzopyran-7-one, 2-(1-(beta-D-glucopyranosyloxy)-1-methylethyl)-2,3-dihydro-, (2R)-,
7H-Furo[3,2-g][1]benzopyran-7-one, 2-[1-(.beta.-D-glucopyranosyloxy)-1- methylethyl]-2,3-dihydro-, (2R),
7H-Furo[3,2-g][1]benzopyran-7-one,2-[1-(b-D-glucopyranosyloxy)-1-methylethyl]-2,3-dihydro-,(2R)-,
nodakenetin glucoside,
C20H24O9,
CID73191,
AR-1D5656,
ACN-047243,
C20-H24-O9,
2-[1-(beta-D-Glucopyranosyloxy)-1-methylethyl]-2,3-dihydro-7H-furo[3,2-g][1]benzopyran-7-one,
51677-99-7,